SPL (Electronic Reg and Drug List)

Download Report

Transcript SPL (Electronic Reg and Drug List)

SPL R4 : Listing Terminology & Lifecycle Management

CDR Vada Perkins, USPHS FDA/CBER/OD

1

Controlled Terminology and Coding

  Improved access to product information by health care providers and patients  Reduce medical errors and improve patient care   Data integration/evaluation Improved functionality across different data systems Immediate access to information 2

Terminology

   FDA has been working with a number of organizations to develop and maintain terminology for electronic drug registration and listing. Terms and codes used for electronic drug registration and listing are available for use in the SPL file at no cost. Links to the different terminologies are available on the FDA Web site. 3

Terminology Maintenance Organizations How to obtain the terms and codes used for electronic drug registration and listing 4

Source: Product Data Elements

 Health Level Seven (HL7): www.hl7.org/    Standards developing organization accredited by the American National Standards Institute (ANSI) Support message standards for the exchange and interoperability of electronic health records. SPL specification was initially developed by a group within the HL7 Regulated Clinical Research Information Management Technical Committee 5

SPL Terminology

                      

Terminology for Drug Establishment Registration and Drug Listing and Content of Labeling

Route of administration Dosage form Package type Units of measure and units of presentation Color Shape Coating Size Scoring Imprint codes Symbols SPL DEA Schedule Section headings Code system object identifiers (OIDs) Document Type including Content of Labeling Type Time Units: Unified Code for Units of Measure (UCUM) Substances/Unique Ingredient Identifiers (UNIIs) Business Operation Marketing Category Marketing Status Equivalence Codes Flavor 6

National Drug Code (NDC) System

  FDA maintains the NDC System as an identifier for drugs. The NDC is a 10 character identifier divided into three segments (labeler, product, and package). Three codes may be derived from the NDC:

NDC Labeler Code

,

NDC Product Code,

and

NDC Package Code

NDC Labeler Code

is a 4 or 5 digit code assigned by FDA to an individual registrant or private label distributor who needs to create NDCs for drug products they plan to market.

NDC Product Code

is an 8 or 9 character code that uniquely identifies a drug product. The

NDC Product Code

consists of the

NDC Labeler Code

assigned by FDA and a 3 or 4 character product segment selected by the company, separated by a hyphen.

NDC Package Code NDC Product Code

is a 10 character code that uniquely identifies a drug product in final package form. The NDC Package Code consists of the and a 1 or 2 character package segment selected by the company, separated by a hyphen. 7

NDC

 Each marketed drug product in final package form has one

NDC Package Code

.

 NDC Labeler Codes are requested through electronic registration and listing using SPL Files * In addition to the NDC System, FDA maintains the FDA Submission Tracking System for providing unique identifiers for applications (e.g., ANADA, ANDA, BLA, NADA, and NDA) and is obtained by the applicant through the application process.

8

United States Pharmacopeia (USP)

 FDA along with USP maintains the preferred names of ingredients and the

Unique Ingredient Identifiers (UNII)

using the FDA Substance Registration System (SRS).

 These names and identifiers are accessible through USP Web site at http://www.usp.org

and publications, the FDA Web site at http://www.fda.gov/oc/datacouncil and the NCI Thesaurus Web site at http://evs.nic.nih.gov

.

*Additional ingredient identifiers may be requested though FDA by sending a request to [email protected]

.

9

FDA/Substance Registration System 

www.fda.gov/oc/datacouncil/SRS.htm

 Unique Ingredient Identifier (UNII) 

Active ingredient

Active moiety

10

Unique Ingredient Identifier (UNII) Codes

 Joint FDA/USP Substance Registration System (SRS) to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices.

 Non-proprietary, free, unique, unambiguous, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information 11

UNII Assignment

 In order to receive a UNII, an ingredient must be a ‘substance’, which is defined as “Any physical material that has a discrete existence, irrespective of origin.” Products will not be assigned a UNII. 12

SPL: Product Data Elements

     

Ingredients

Active and inactive ingredient and active moiety name and code (Unique Ingredient Identifier (UNII) from FDA SRS)  Active and inactive ingredient strength (NCI Thesaurus, UCUM)

Dosage form

(NCI Thesaurus)

Appearance

(imprint, color, shape, size, score, coating, symbol) (NCI Thesaurus and HL7)

Route of administration

(NCI Thesaurus)

DEA schedule

(NCI Thesaurus) 13

SPL: Product Data Elements

 

Product

Proprietary and nonproprietary name and code (FDA DRLS)  

Packaging

Package type

(FDA DRLS) (NCI Thesaurus), quantity and code 14

National Cancer Institute (NCI) Thesaurus  www.

nciterms.nci.nih.gov

 Published monthly  Covers vocabulary for clinical care and research 15

National Cancer Institute

          NCI maintains a number of different terminologies used in electronic drug registration and listing including:

dosage form routes of administration package types DEA schedule product color product shape flavors business operations marketing

These codes on located in the NCI Thesaurus and may be accessed through the NCI Web site at http://evs.nci.nih.gov

and FDA web site at http://www.fda.gov/oc/datacouncil/spl.html

.

Additional terms and codes for use in registration and listing may be requested though FDA by sending a request to [email protected]

.

16

Dun and Bradstreet (D&B)

   Dun and Bradstreet assign and maintain the Data Universal Numbering System (DUNS) Number as an identifier for businesses. Each business location (e.g., headquarters, branch, subsidiary, establishment, importer, US agent) has its own unique

DUNS Number

.

If the

DUNS Numbers

for a location is not known, it may be looked up or requested by going to the D&B Web site at http://www.dnb.com

.

DUNS Numbers are assigned by D&B within 30 business days of a request without charge.

           The following information on the business entity is used to obtain a new DUNS Number from D&B:

Full legal name of Business, Business Address, City, State, Zip code, Country, Local Phone Number, Name of CEO/Business Owner Legal structure of the business (e.g., Corporation, Partnership), Year Business Started Primary Line of Business (e.g. pharmaceutical manufacturer), Total Number of Employees (including principals, and part-time).

17

The Unified Code for Units of Measures (UCUM):  www.regenstrief.org

 Code system intended to include

all

units of measures being contemporarily used in international science, engineering, and business 18

Logical Observation Identifier Names and Codes (LOINC®):  www.

loinc.org

 Code system for reporting laboratory and other clinical observations 19

Regenstrief Institute

The Regenstrief Institute maintains a number of different terminologies used in electronic drug registration and listing including:   

document types section headings units of measure

  These terminologies are located in the Logical Observation Identifiers Names and Codes (LOINC) and Unified Codes for Units of Measure (UCUM). Both of these terminologies are available at http://www.regenstrief.org

and at other locations.

*Send a request to [email protected] for additional terms and codes for use in registration and listing.

20

National Archives and Records Administration (NARA)

 NARA maintains the codes for FDA regulations in the

Code of Federal Regulations

.  The codes for the various regulations are available through the NARA publications and at the Government Printing Office Web site at http://www.gpoaccess.gov

.

21

SPL Terminology

                      

Terminology for Drug Establishment Registration and Drug Listing and Content of Labeling

Route of administration Dosage form Package type Units of measure and units of presentation Color Shape Coating Size Scoring Imprint codes Symbols SPL DEA Schedule Section headings Code system object identifiers (OIDs) Document Type including Content of Labeling Type Time Units: Unified Code for Units of Measure (UCUM) Substances/Unique Ingredient Identifiers (UNIIs) Business Operation Marketing Category Marketing Status Equivalence Codes Flavor 22

Term/Code Unavailable?

 If a term/code is unavailable, please contact [email protected]

.

**

Applicant can provide reference source(s) 23

SPL Lifecycle Management

 NDC Labeler Code  Establishment Registration  Drug Listing/Content of Labeling 24

NDC Labeler Code Assignment

 NDC Labeler Codes are assigned by FDA to registrants and private label distributors   NDC to be assigned to drug products for marketing. Electronic drug registration and listing uses SPL files for managing

NDC Labeler Code

assignment 25

NDC Labeler Code Request

  NDC Labeler Code request SPL file is

NDC Labeler Code Request

 Document identifiers – These identifiers are used for tracking the different versions of the document.

id

– uniquely identifies a specific document. The id is a Globally Unique Identifier (GUID) 

setId

– uniquely identifies a group of versions of a document. The setId is also a GUID. When there is a change in a document, the

id

changes but the

setId

stays the same.

 

Version number

– is used to track SPL files successfully processed by the FDA system. Version number is increased for each subsequent SPL file successfully submitted using the same

setId

.

Effective time

– the date of the submission.

26

NDC Labeler Code Request Validation Error

  SPL file cannot be processed because it fails validation a report on the validation error is sent from FDA to the contact person  Correct the error in the SPL file and resubmit the SPL file using the same

setId

as the rejected SPL file 27

Corrections to a Submitted NDC LCR File

 Edit the SPL file and submit the new SPL file with: 

new

id 

new

version number 

original

setId 28

Unused NDC Labeler Code

 NDC Labeler Code must be used to create a NDC for a listed drug within 24 months of the initial assignment  Code will be reassigned 29

NDC Labeler Code Information Update

 Update the previous SPL file to include:  new information without changing the other existing information  submit the new SPL file using:  

new

id

new

version number 

original

setId.

30

2

nd

NDC Labeler Code Request

 Only one NDC Labeler Code is associated with each NDC Labeler Code request.

 Submit a separate SPL file with a different setId if a second NDC Labeler Code is requested 31

Establishment Registration

  Establishments are registered by the owners or operators of the establishments (registrants).

Electronic drug registration and listing uses SPL files for managing establishment registration     The

document type

used for registration include:

Establishment registration No change notification Out of business notification

.

**The registrant provides their

business name

and

DUNS Number

and contact information.

**The type of contact information is the same as described in the section on requesting a NDC Labeler Code.

32

Initial Submission for Establishment Registration

  Registrants include one or more establishments for each Establishment Registration SPL file Even if the establishments have been registered in the past.

33

Establishment Registration Validation Error

    SPL file can not be processed because it fails validation Report on the validation error is transmitted from FDA to the contact person. Correct the error in the SPL file Resubmit the SPL file using the

same

setId as the rejected SPL file.

34

Corrections to a Submitted SPL File

    Edit the SPL file and submit the new SPL file using:

new

id

new

version number

original

setId 35

Update Information for a Registered Establishment

  Update the previous SPL file to include: new information without changing the other existing establishment registration information     Submit the new SPL file using:

new

id

new

version number

original

setId 36

Addition of New Establishment

  Update the previous SPL file to include: Information on a new establishment without changing the information on the other establishments     Submit the new SPL file using:

new

id

new

version number

original

setId 37

Remove a Previously Registered Establishment

 Update the previous SPL file by removing the specific establishment information without changing the existing information on the other establishments     Submit the new SPL file using:

new

id

new

version number

original

setId 38

No Changes to Registration Information

 Update information once a year  If no change, submit an SPL file with the document type-No change notification   

new

id

new

version the

original

setId. 39

Registrant Out of Business

    Submit an SPL file with the document type: Out of

business notification

using:

new

id

new

version number

original

setId **Registrant and establishment information is not included with a SPL with the document type Out of

business notification

.

40

Marketing Category

   

Marketing category

is included for each product. 

If m

arketing category is a marketing application (e.g., NDA, ANDA)

Application Number

is included.

If

marketing category is a monograph

Code of Federal Regulation citation

is included.

 If Bulk ingredient is included

Master File

number is included.

41

Marketing Status

   Marketing status Describes the date when the SPL file is added to the public repository of SPL files and, When the SPL file is removed from the public repository  The expiration date of the last lot released to the marketplace provides a date when the SPL file should be removed.

42

Product Characteristics

 Product characteristics may include: 

Color,

size,

shape

,

scoring

and imprint (solid forms),

flavors, and

general substances that the product

contains

.   A standardized image of the solid dosage form may be included. Obtained from the FDA for inclusion with the listing information.

43

Route of Administration

 The routes of administration

approved

drug product are included.

for the 44

Content of Labeling

  The content of the labeling provided with drug listing (e.g., package insert, consumer labeling, carton labels and container labels) is included in the same SPL file as the other drug listing information. Carton and container labels include the content of the Drug Facts or equivalent for animal drug products and the content of the principal display panel including the image of the entire label as a single jpg file.

45

Drug Listing Release 3 SPL Previously Submitted

    Update the previous SPL release 3 file to a SPL release 4 file with the additional drug listing information and submit a new SPL file using

new

id

new

version number

original

setId 46

Initial Drug Listing Submission

 The drug listing information is provided in a single SPL file even if the drug products have been listed in the past  More than one drug product are included in a single SPL file when the products relate to the same content of labeling though each drug product is included in only one SPL file  Drug listing includes all jpg files associated with the content of labeling  Drug listing SPL file is separate from the SPL file for NDC Labeler Code request and the SPL file for establishment registration.

47

SPL: Private Label Distributor

  Private label distributor includes all of the information that would have been supplied by the registrant to include: All establishments involved in the manufacturing and processing of the drug product   Registrant does

not

submit a SPL file for this drug product. If the private label distributor chooses not to provide the SPL file with the drug listing information, then the registrant provides the SPL file. 48

SPL Listing: Registrant Lists a Drug for a PLD

 Private label distributor chooses not to provide the SPL file with the drug listing information     Registrant provides the SPL file to include: Name of the private label distributor as the labeler Itself as the registrant All establishments involved in the manufacturing and processing of the drug.

** The drug listing information is provided in a single SPL file even if the drug products have been listed in the past.

49

SPL: Listing with More than One Registrant

  More than one registrant is involved in manufacturing and processing a single drug product (e.g., contract manufacturers), Only one registrant provides the SPL file with the drug listing information for the drug product    The registrant who provides the SPL file includes: Own establishments All establishments of all other registrants involved in the manufacturing and processing of the drug product 50

SPL: Listing for Bulk Ingredients

 Registrant provides the SPL file with the drug listing information for the bulk drug ingredients (e.g., active pharmaceutical ingredient). 51

SPL Listing: Registrant Using a Marketed Bulk Ingredient

 The registrant provides the SPL file with the drug listing information for its drug product including the NDC Product Code for the marketed bulk drug ingredient. 52

SPL Listing: Registrant Repacking or Relabeling a Marketed Drug Product

  The repacker or relabeler provides the SPL file with the drug listing information for its drug product Includes the NDC Product Code for the source marketed drug product 53

Kit: Two or More Drug Products

  The registrant or private label distributor provides the SPL file with the drug listing information for its kit.   Includes drug listing information for each drug product in the kit (component) NDC Product Code NDC Package Codes (if applicable) 54

SPL: Drug Listing Validation Error

 SPL cannot be processed if it fails validation (pass/fail)  Report on the validation error transmitted from FDA to the contact person  Correct the error in the SPL file  Resubmit the SPL file  the

same

set Id as the rejected SPL file 55

Correct a Mistake in Drug Listing SPL File

    Edit the SPL file to correct the mistake and submit the new SPL file

new

id

new

version number

original

setId 56

Update Information for Electronic Drug Registration and Listing

  Update the previous SPL file so it includes the new information without changing the other existing drug listing information Submit the new SPL file 

new

id 

new

version number 

original

setId 57

Change in C of L Requiring Prior Approval

 Only Content of Labeling that accompanies a marketed drug product is used for electronic drug registration and listing  Content of Labeling requiring prior approval not included   The SPL file for the content of labeling requiring prior approval uses the

same

setId as the SPL file used in electronic registration and listing. Upon approval, the revised content of labeling is included in the SPL file provided for electronic registration and listing as described when changing content of labeling not requiring prior approval.

58

Change in C of L Not Requiring Prior Approval

  Update the previous SPL file by changing the content of labeling without changing the other existing drug listing information    Submit the new SPL file

new

id

new

version number

original

setId 59

Add a Package Configuration

 Update the previous SPL file by adding the new package configuration without changing the other existing drug listing information  Submit the new SPL file 

new

id 

new

version number 

original

setID 60

Remove a Package Configuration

 Update the previous SPL file by removing the specific package configuration without changing the other drug listing information  Submit the new SPL file 

new

id 

new

version number 

original

setId 61

Add a Drug Product Strength

 Update the previous SPL file by adding the information on the new drug product strength without changing the other drug listing information  Submit the new SPL file 

new

id  

new

version number

original

setId 62

Discontinue One of Multiple Drug Product Strength

 Update the previous SPL file by removing the information on the specific drug product strength without changing the other drug listing information  Submit the new SPL file 

new

id 

new

version number 

original

setId 63

Discontinue Final Drug Product

 Update the previous SPL file by changing the

marketing status

of the remaining drug product to “completed” and provide the expiration date for the last lot marketed in the appropriate SPL data elements  FDA will remove the SPL file from the public repository on the expiration date 64

FDA Data Standards Council-Supporting Documentation

 http://www.fda.gov/oc/datacouncil/spl.html

 Directions for obtaining the SPL standard and schema from HL7  Links to the SPL FDA Implementation Guide, the companion document to the HL7 SPL standard providing additional details on creating SPL files  Link to the

Guidance for Industry: Providing Regulatory Submissions in Electronic Format - Content of Labeling

Guidance for Industry: Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing (Draft Guidance)

 Style sheet files for viewing SPL content of labeling files 65

Thank You

66